The value of local malaria strains for serological studies: local strains versus Palo Alto reference strain by Fode Diop et al.
Diop et al. Malaria Journal  (2015) 14:229 
DOI 10.1186/s12936-015-0734-zRESEARCH Open AccessThe value of local malaria strains for serological
studies: local strains versus Palo Alto reference
strain
Fode Diop1,2, Gora Diop2,3, Makhtar Niang1, Babacar Diouf1, Daouda Ndiaye4, Vincent Richard5
and Aissatou Toure Balde1*Abstract
Background: The standardization of the type of crude Plasmodium falciparum extracts for assays to evaluate the
overall anti-blood-stage immune response in humans may be beneficial to malaria pre-elimination programmes.
However, there is no consensus on which strain is appropriate for routine analyses. This study aimed to compare
the responses of malaria IgG antibodies in serum collections from Dielmo and Ndiop to crude extracts of
merozoites and schizonts of local and reference strains of P. falciparum.
Methods: Malaria antibodies were evaluated using serological tests for exposure to three local strains (0703, F15
and F16) and the P. falciparum reference Palo Alto strain (PA). A total of 218 sera collected in 2000 from inhabitants
of the villages of Dielmo and Ndiop were used: 142 from Dielmo and 76 from Ndiop. The biological collection was
used to evaluate by ELISA the prevalence of IgG antibodies against crude merozoite and schizont extracts. The
genetics of the local and reference strains were compared.
Results: There was genetic divergence between strains 0703, F15, F16 and PA. IgG responses against local and
reference strains correlated well (0.6 to 0.8; p < 0.01). Ig G responses were highest to schizont and merozoite
extracts from the field strain of P. falciparum 0703 adapted to in vitro culture. Extracts of P. falciparum strain 0703
isolated from a subject in Dielmo was the most widely recognized [91.3 % (199/218) and 81.2 % (177/218) for schizonts
and merozoites, respectively], although the responses were high for merozoites from PA [85.3 % (186/218)] the reference
strain, and the two strains isolated from subjects living in Dakar: F15 [90.4 % (197/218)] and F16 [72.5 % (158/218)].
Conclusions: For serological studies, the local strain provided the most complete picture of exposure to transmission
and malaria prevalence in the local context. However, for the standardization of this method by different laboratories,
the reference strain appeared to perform sufficiently well to be used for the evaluation of malaria control programmes.Background
Programmes of pre-elimination of malaria have been un-
derway in Senegal since 2010, and the burden of malaria
has decreased substantially [1–3]. The changes in the
epidemiology nevertheless need to be monitored with
effective tools that allow changes in patterns of trans-
mission to be documented. In the context of pre-
elimination, serological markers are promising tools for
detecting exposure to malaria and evaluating malaria
control efforts. This is particularly true for areas where* Correspondence: atoure@pasteur.sn
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limit of microscopy and where assessing transmission
intensity directly by determining the exposure to malaria-
infected mosquitoes (entomological inoculation rate
[EIR]) has become difficult [4, 5]. Serological markers
have been suggested to be fully informative indicators
of the dynamics of malaria transmission [6, 7]. Various
methods based on characterized antigens have been
used to measure specific humoral responses to malaria
and to evaluate transmission intensity [6, 8]. One of
the limitations of these methods is that the immune re-
sponse to a given antigen may depend on genetics, and
be affected by polymorphisms [9]. However, responses
to parasite crudes extracts, which are mixtures oficle distributed under the terms of the Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any
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constraints [9, 10]. Crude merozoite and schizont ly-
sates have been used to explore the response to a wide
panel of parasite antigens and material derived from
parasite lysates has been used to detect antibodies spe-
cific to Plasmodium falciparum blood stages [11, 12].
Antibody responses to crude extracts of schizonts of a
local P. falciparum strain reflected the changes of
malaria profiles due to various interventions [13].
However, the antigenic content of such extracts is
poorly defined and may vary, depending upon the type
of crude extract and the strain used [12]. These issues
complicate the comparison of seroepidemiological ana-
lyses conducted in different laboratories and the inter-
pretation of results. There is currently no consensus
on the type of crude extract, or strain, or P. falciparum
antigen to be used in standard assays for the evaluation
of the overall anti-blood-stage immune response in
humans.
This work aimed to compare merozoite and schizont
extracts from local and reference strains to identify the
most suitable extract for routine analysis of antibody re-
sponses to P. falciparum blood stages in malaria-exposed
individuals.
Methods
Populations and serum collection
Since 1990, the Dielmo project was established between
the Institut Pasteur of Dakar, the Institute for Research
and Development, the Senegal Ministry of Health and
the University of Dakar. This project was initially approved
by the Ministry of Health of Senegal and the assembled
village population. The project aim was to study the nat-
ural history of malaria and more specifically the determi-
nants of protection and biological markers associated to
protection/exposure through longitudinal follow up of the
inhabitants of the villages of Dielmo and Ndiop [14]. For
this purpose clinical, entomological and parasitical studies
were performed and blood samples were collected for
immunological studies and stored in a biobank.
Written informed consent from individuals enrolled in
the project and parents or guardians of children who
provided blood samples was obtained. The consent to
participate to the project was regularly renewed. Approval
was obtained from the National Ethics Committee for
Health Research of Senegal and ad-hoc committees of the
Ministry of Health, the Pasteur Institutes (Dakar and
Paris), and Institute for Research and Development did
audits regularly.
This study is based on the samples stored in the bio-
bank and is in line with the objectives of the Dielmo
project [14].
This comparative analysis study was conducted using
sera collected in 2000 from inhabitants of the villages ofNdiop and Dielmo. A total of 220 sera from individuals
less than 20 years old were used: 76 from Ndiop and 141
from Dielmo. In 2000, Ndiop and Dielmo had differ-
ences in malaria endemicity and contrasting contexts of
transmission: in Ndiop, transmission was seasonal with
an entomological inoculation rate of 80 infectious bites/
person/year, whereas in Dielmo the transmission was
continuous with 482 infectious bites/person/year [15].
Blood samples were collected before the end of the rainy
season in 2000 when transmission was high in both
Ndiop and Dielmo [16]. The sera were separated from
blood cells and stored at −20 °C until use for immuno-
logical studies.
Crude antigen extracts
Four parasite strains (0703, F15, F16 and PA) were used
in this study and continuously cultured on O+ erythro-
cytes in RPMI containing 0.5 % Albumax using the can-
dle jar method [17]. Three field strains of P. falciparum
isolated from clinical or asymptomatic malaria-infected
Senegalese patients and adapted for in vitro culture as
described elsewhere [13, 18]. The 0703 strain was iso-
lated from an inhabitant of Dielmo on November 1991
and successfully adapted to continuous in vitro culture
thereafter [19]. F15 and F16 strains were isolated in
Dakar on February 2010 and March 2010, respectively,
from patients of the medical analysis laboratory and
were also successfully adapted to continuous in vitro
culture. The Palo Alto Uganda reference strain FCR3
(PA, Uganda) had been isolated from a Ugandan patient
[20] and had been routinely cultured for years in the
laboratory. Strains were cultured separately at different
time periods to avoid cross contamination between
strains. Extracts of schizonts of P. falciparum were pre-
pared as previously described [12, 18]. Briefly, for schiz-
ont extracts, after centrifugation, one volume of the
pellet was lysed in three volumes of sterile distilled water
and vortexed for homogenization; the extracted schiz-
onts were frozen without further centrifugation in liquid
nitrogen in working aliquots. The merozoite extract was
prepared from synchronous parasites as described by
others [12, 21]. In brief, merozoites were collected by
stepwise centrifugation of culture supernatants at 2,000
and 4,000 g, washed three times in sterile phosphate buff-
ered saline (PBS), counted, and frozen in liquid nitrogen.
DNA extraction and genotyping
Genomic DNA was extracted from wild field Senegalese
isolates of P. falciparum adapted in continuous culture
(0703, F15, F16) and from the PA reference strain using a
QiAmp ® DNA Blood MiniKit (Qiagen Catalogue # 51106)
according to the manufacturer’s recommendations. Nested
PCR genotyping was performed for the variable block 3
region of msp-2, considered to be the most informative
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diversity [22]. The initial PCR amplification with primers
pairs flanking the msp-2 (block 3) region was followed by
individual nested PCR reactions using family-specific
primers for msp-2 (FC27 and 3D7/IC), using previously
described standard protocols [23]. The PCR conditions
and primers sequences were as described by Snounou
et al. [24, 25]. The PCR-amplified msp-2 products were
separated by electrophoresis on 1.5 % agarose gel and the
fragments were visualized under UV transillumination
with ethidium-bromide. The sizes were estimated by com-
parison with a 100 bp (Hyperladder, Bioline®) molecular
weight marker.
ELISA assay
ELISA Maxisorp plates (Nunc, Roskilde, Denmark) and
a dose effect assay using positive control sera were used
to determine the optimal dilution of the extracts to use
in the assay. The optimal dilution found for each extract
was used for coating the plates. Plates were coated with
100 μl of water-soluble extract for all crude extracts.
Non-infected red blood cell extract was prepared in the
same conditions, incubated overnight at 4 °C and
washed. Then, 200 μl of a blocking buffer (2 % BSA in
PBS with 0.05 % Tween) was added to each well and the
plates were incubated for 1 h at 37 °C. Plasma samples
were diluted at 1/200 in a dilution buffer (1 % BSA in
PBS with 0.05 % Tween) and 100 μl of diluted serum
was distributed into each well. Negative and positive
controls were included on each plate: positive controls
were from Dielmo/Ndiop hyperimmune individuals and
negative controls were from European individuals. Poly-
clonal goat anti-human IgG conjugated to peroxidase at
a dilution of 1/6,000 in the dilution buffer (1 % BSA in
PBS-Tween 0.05 %) was then added. Bound peroxidase
was detected with ortho-toluidine /H2O2 (100 μl) and
the reaction was stopped by addition of 4 N H2SO4
(50 μl/well). Between each incubation phase, the ELISA
plates were washed extensively with PBS-0.05 % Tween.
For each assay, plasma samples were tested in duplicates
on the same ELISA plate. The optical density (OD) at
450 nm was read in a BIO-RAD Microplate Reader
(iMark) [12]. The final OD value of each serum tested
was obtained by calculating the mean OD of the dupli-
cates. Sera from negative controls were used to define
the cutting-off value for positivity based on an optical
density of 2 fold the mean optical density (OD) of these
negative controls. Results was expressed as OD ratio cal-
culated as mean OD test/mean OD neg. and a ratio OD
test/mean OD neg >2 was defined as cutting-off value
for positive response. Inter-assay variations for positive
controls did not exceed 20 %. The reproducibility of this
technique has been found satisfactory with coefficients
of variation of 4 % by using two positive controls (twodifferent pools of hyperimmune serums), 10 negative
controls and the same crude extract preparation on each
plate [12, 26].
Statistical analysis
R software was used for statistical analysis. Non paramet-
ric tests (Kruskal Wallis, Wilcoxon) and the Spearman test
were used to study non-parametric quantitative variables.
Fisher’s exact test was used for qualitative variables.
Differences were considered statistically significant for
p < 0.05 [27].
Results
Genotyping analysis
Allelic diversity between the four parasite strains (F15,
F16, 0703 and PA) was determined by assessing length
polymorphism within the msp2 locus (Fig. 1). The two
allelic types of msp2 were unequally distributed within
the different parasite strains tested. Although two pre-
dominant IC3D7 allelic types were detected in all para-
sites strains, the number of FC27 allelic types differed
between the different strains. The two most frequent
IC3D7 alleles harboured by strain F16 were unique and
different from those detected in the other parasite
strains. For the FC27 allele family, no amplification prod-
uct was detected for strain F16 whereas one, two and four
bands were detected for 0703, F16 and PA, respectively.
The single FC27 allele detected in strain 0703 was absent
from all other parasite strains. The genotypes identified in
the F16 strain were different from those of PA. These find-
ings clearly demonstrate that the different parasite strains
used in this study were genetically divergent.
Correlation between antibody levels to crudes extracts
The immune responses to the various strains were ana-
lysed by Spearman correlation. Individual antibody re-
sponses to crude PA, F15 and F16 schizont extracts were
positively and significantly correlated with the antibody
levels to the 0703 schizont extract (rho values of 0.62,
0.6, and 0.56 respectively for PA, F15 and F16; p < 0.01)
(Fig. 2). There was a strong and positive correlation
between antibody levels against crude F15, F16 and
PA schizont extracts (rho values ranged from 0.7 to
0.8; p < 0.01). The OD ratios obtained with IgG against
PA, F15 and F16 merozoites was also significantly corre-
lated with OD ratios obtained for 0703 merozoites (rho
values of 0.73, 0.71, and 0.72 respectively for PA, F15 and
F16; p < 0.01) (Fig. 3).
Comparison of antibody levels against crude schizont
extracts
The mean antibody responses measured as OD ratios
were 2.86 for schiPA, 3.89 for schiF15, 3.01 for schiF16
and 4.34 for schi0703 (Fig. 4). The Kruskal Wallis test
Fig. 1 PCR analysis of the polymorphic region of msp2 (block 3) of different P.falciparum isolates from Dielmo (0703), Dakar (F15 and F16) and
Uganda (PA). The DNA size marker is a 100 bp ladder
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against schiPA than against 0703 and F15, but that it
was not significantly different to that against F16. The
distribution of anti P. falciparum antibodies indicated
that significantly higher IgG absorbance values were ob-
tained using crude schi0703 extract than other extracts,
with an overall p < 0.01.
Comparison of antibody levels against crude merozoite
extracts
Mean antibody responses, expressed as OD ratios were
4.44 for meroPA, 3.63 for meroF15, 2.79 for meroF16




































Fig. 2 Correlation between Ab responses to schizont crude extractsmero0703 was significantly higher than other values
except for meroPA for which the difference was not
significant. The antibody response against meroF16
was significantly lower than those against other
strains (p < 0.01). The response against meroPA was
significantly higher than those against meroF15 and
meroF16 (p < 0.01).
Cross comparison of antibody levels against crude
schizont and merozoite extracts
Antibody responses against schizont extracts and merozo-
ite extracts were determined and compared (Fig. 6). The
mean levels of antibody responses against merozoites were4 5 6
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Fig. 3 Correlation between Ab responses to merozoite crude extracts
Diop et al. Malaria Journal  (2015) 14:229 Page 5 of 9significantly higher than those against schizonts for the
strains PA and F16 (p < 0.01), but there was no difference
for strains F15 (p = 0.06) and 0703 (p = 0.26). The mean
level of the antibody response against 0703 was higher
than those of the other strains although the difference
with meroPA was not significant.Fig. 4 Comparison of antibody responses against schizont crude extracts (
[Foundation Pasteur P. falciparum 16], 0703 [P. falciparum 0703]. Measurem
the villages of Dielmo and NdiopPercentages of positive responders against crude
merozoite and schizont extracts
The percentages of positive responders (OD ratio > 2) to
merozoite and schizont crude extracts were compared
(Fig. 7 and Table 1). There was significant differences for
reference strain PA merozoite extract (85.3 %) vs.75.2 %PA [Palo Alto], F15 [Foundation Pasteur P. falciparum 15], F16
ents were performed with sera collected in 2000 from inhabitants of
Fig. 5 Comparison of antibody responses against merozoite crude extracts. (PA [Palo Alto], F15 [Foundation Pasteur P. falciparum 15], F16
[Foundation Pasteur P. falciparum 16], 0703 [P. falciparum 0703]. Measurements were performed with sera collected in 2000 from inhabitants of
the villages of Dielmo and Ndiop
Fig. 6 Cross comparison of antibody responses between Plasmodium falciparum schizonts and merozoites. (PA [Palo Alto], F15 [Foundation
Pasteur P. falciparum 15], F16 [Foundation Pasteur P. falciparum 16], 0703 [P. falciparum 0703]. Measurements were performed with sera collected
in 2000 from inhabitants of the villages of Dielmo and Ndiop
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Fig. 7 Positive responders to crude extracts of four Plasmodium falciparum strains (PA [Palo Alto], F15 [Foundation Pasteur P. falciparum 15], F16
[Foundation Pasteur P. falciparum 16], 0703 [P. falciparum 0703]. Measurements were performed with sera collected in 2000 from inhabitants of
the villages of Dielmo and Ndiop
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71.1 %), F15 (90.4 % vs 77.5 %) and 0703 (91.3 % vs.
81.2 %) (Table 1). The percentage of positive responders
to mero16 (72.5 %) was significantly lower than to mer-
oPA (85.3 %), mero15 (90.4 %) and mero0703 (90.4 %).
However, there was no difference in the frequency of
responders to F15 and 0703 (Fig. 7). The percentage of
positive responders against schi0703 (81.2 %) was signifi-
cantly higher than those to PA (75.2 %) and F16 (71.1 %)
strains but not different to the value for schiF15
(77.5 %).
Discussion
The study reported here involved an analysis, by an
Enzyme Linked ImmunoSorbent Assay approach, of IgG
responses to extracts of merozoites and schizonts from
local and reference strains; the aim was to identify the
most suitable extract for routine analysis of the levels ofTable 1 Percentage of positive responders to crude extracts of
four Plasmodium falciparum strains
Strains Antigens
Schizonts (%) Merozoites (%)
PA 75.2 (164/218) 85.3 (186/218)
F15 77.5 (169/218) 90.4 (197/218)
F16 71.1 (155/218) 72.2 (158/218)
0703 81.2 (177/218) 91.3 (199/218)
Measurements were performed with sera collected in 2000 from inhabitants of
the villages of Dielmo and Ndiop
PA Palo Alto, F15 Foundation Pasteur P. falciparum 15, F16 Foundation Pasteur
P. falciparum 16, 0703 P. falciparum 0703antibodies to P. falciparum blood stages in individuals
exposed to malaria.
Samples from immune individuals from Dielmo and
Ndiop were tested for their reactions to crude extract of
four P. falciparum strains. The mps2 genotype was used
here to compare the parasite strains included in the
study. Various genotypes were identified, based on PCR
fragment size, revealing genetic diversity of the parasite
strains included [25].
The IgG responses obtained with the four strains were
strongly and positively correlated. The strong and posi-
tive correlation between strains PA, F15, F16 and 0703
for IgG antibody levels observed indicates that any of
these crude extracts could be used to determine total
anti-P. falciparum antibody responses in malaria en-
demic areas. The correlation between local and the
reference strain means that laboratories could use ref-
erence strains for routine analysis; this is an advantage
because adapting and maintaining wild parasite strains
in continuous in vitro culture is complicated, and often
unsuccessful [28].
Immunoassays using crude extracts from local
strains as antigens are useful for evaluating immunity
but, often, require the adaptation of P. falciparum
isolates to continuous in vitro cultivation [13, 19]. To
date, no clear consensus exists on which strain or what
type of P. falciparum extract (merozoites or schizonts)
to use for serological studies. There is a need for a
standard assay, in particular for inter-laboratory com-
parisons of immune responses against strains from
different origins.
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and merozoites of strain 0703, the local strain isolated in
Dielmo and Ndiop, are consistent with the study popula-
tion’s contact with this local strain, and the higher preva-
lence of positive responders against merozoites and
schizonts confirmed the good recognition for this strain.
These observations are in agreement with previous stud-
ies [13]. A high level of antibody recognition of strains
PA, F15, and F16 was also obtained in samples from
both Dielmo and Ndiop villages. This finding is consist-
ent with studies conducted in Mali, Gambia, Cambodia
and Peru [29, 30].
Although there was a significantly higher signal de-
tected for IgG responses to 0703 than to other strains,
notably F15, the frequencies of responders were less dif-
ferent: 81.2 % (177/218) vs 77.5 % (169/218) and 91.3 %
(199/218) vs 90.4 % (197/218) for schizont and merozo-
ite extracts, respectively. Therefore, it is not clear
whether the high signal reflects a better IgG reactivity to
a geographically-matched isolate or an immune response
strongly elicited by more frequent inoculation. But what-
ever the origin of this higher signal the fact that frequen-
cies of responders are less different between strains leads
to the conclusion that for standardization using the par-
ameter of frequency of responder as an indicator of mal-
aria dynamics could be a better choice. This point raises
the important issue of the cutting-off value to adopt for
defining positivity. In this study the cutting-off chosen
was values of OD ratio (mean sera OD/mean controls
OD) > 2. This is an arbitrary value but, in the authors’
opinion, this value is high enough to exclude very low
titers which could be difficult to interpret. Another
method of defining positivity could be to adopt for
positivity values > mean OD of controls + three standard
deviations. This leads to higher number of positive re-
sponders as in these assays the standard deviations of
controls are very low.
In high to moderate transmission areas as those stud-
ied here very low cut-off values would not be suitable
for following malaria transmission dynamics as it could
be not enough sensitive. But in areas where malaria
transmission is very low and where elimination is envis-
aged, lower cut-off than ratio > 2 could probably be
though.
The greater recognition of strain 0703 suggests that
the use of a local strain may allow optimal determination
of total anti-falciparum Ab responses in an area. These
observations are also relevant to issues about the malaria
indicators used in serological studies and some of the in-
coherencies related to the crude extract at different
scales in dings for the level and prevalence of antibodies
revealed no difference between merozoites and schizonts
of the local strain [30]. Therefore, schizont extracts may
be more appropriate for laboratories as preparation ofcrude extracts of antigens is more straightforward from
schizonts than from merozoites.
The findings reported herein indicate that, for the ana-
lysis of serological data, distinctions should be made be-
tween local and reference strains. The use of a reference
strain should help with obtaining homogeneous and
comparable data from different laboratories in different
study areas and be useful for monitoring. However, local
strains may be valuable for detecting low level infections
in local context, although further work is needed to
confirm this possibility.
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